Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 22Lymphoma, Follicular 14Lymphoma, B-Cell, Marginal Zone 11Lymphoma 11Lymphoma, Mantle-Cell 10Lymphoma, Non-Hodgkin 7Lymphoma, Large B-Cell, Diffuse 6Neoplasms 4Lymphoma, B-Cell 4Recurrence 3Burkitt Lymphoma 3Waldenstrom Macroglobulinemia 1Triple Negative Breast Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Neoplasm, Residual 1Melanoma 1Mature B-cell Malignancies 1Lymphoproliferative Disorders 1Lymphatic Diseases 1Leukemia, Hairy Cell 1Leukemia, B-Cell 1Leukemia 1Heart Failure 1Extensive Stage Small Cell Lung Cancer 1Dendritic Cell Sarcoma, Interdigitating 1Cytokine Release Syndrome 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Carcinoma 1

Interventions

sacubitril and valsartan sodium hydrate drug combination 2dapagliflozin 2Rituximab 2pertuzumab 1pegfilgrastim 1obinutuzumab 1nicotinamide-beta-riboside 1acalabrutinib 1Vincristine 1Valsartan 1Trastuzumab 1Standard of Care 1Specimen Handling 1Pyruvic Acid 1Prednisolone 1Practice Guidelines as Topic 1Ogivri 1Mesenchymal Stem Cell Transplantation 1Lenalidomide 1Eplerenone 1Electronic Health Records 1Echocardiography 1Doxorubicin 1Dexrazoxane 1Cyclophosphamide 1Cardiac Resynchronization Therapy 1Angiotensin-Converting Enzyme Inhibitors 1Adrenergic beta-Antagonists 1Ado-Trastuzumab Emtansine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Heart Failure × obinutuzumab × Clear all
NCT06651970 2026-05-18

Acalabrutinib Monotherapy vs Investigator's Choice of Treatment in Patients With CL Leukaemia and Heart Failure

AstraZeneca

Phase 4 Recruiting
60 enrolled
LymphoidOther hematologic neoplasm

Heart Failure, Lymphatic Diseases, Leukemia, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡